Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1990 4
1991 1
1992 1
1993 1
1995 1
1996 1
1999 2
2001 2
2002 2
2003 1
2006 1
2007 1
2010 2
2011 2
2012 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
[Assessment of hepatitis C networks].
Desmorat H, Couzigou P, Marcellin P; Fédération Nationale des Pôles et Réseaux Hépatites. Desmorat H, et al. Gastroenterol Clin Biol. 2002 Oct;26(10):835-41. Gastroenterol Clin Biol. 2002. PMID: 12434094 Free article. French.
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.
Bronowicki JP, Ouzan D, Asselah T, Desmorat H, Zarski JP, Foucher J, Bourlière M, Renou C, Tran A, Melin P, Hézode C, Chevalier M, Bouvier-Alias M, Chevaliez S, Montestruc F, Lonjon-Domanec I, Pawlotsky JM. Bronowicki JP, et al. Among authors: desmorat h. Gastroenterology. 2006 Oct;131(4):1040-8. doi: 10.1053/j.gastro.2006.07.022. Epub 2006 Jul 24. Gastroenterology. 2006. PMID: 17030174 Clinical Trial.
Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.
Nicot F, Alric L, Barange K, Métivier S, Dramard JM, Combis JM, Castan B, Meurisse JJ, Payen JL, Garipuy D, Desmorat H, Peron JM, Thebault S, Morin T, Renou C, Barel P, Guerin B, Imbert Y, Sire S, Sauné K, Chatelut E, Izopet J. Nicot F, et al. Among authors: desmorat h. J Med Virol. 2011 Mar;83(3):437-44. doi: 10.1002/jmv.21976. J Med Virol. 2011. PMID: 21264864 Clinical Trial.
Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial.
Alric L, Duffaut M, Selves J, Sandre K, Mularczyck M, Izopet J, Desmorat H, Bureau C, Chaouche N, Dalbergue B, Vinel JP. Alric L, et al. Among authors: desmorat h. J Hepatol. 2001 Aug;35(2):272-8. doi: 10.1016/s0168-8278(01)00110-6. J Hepatol. 2001. PMID: 11580151 Clinical Trial.
24 results